Document is current

Any future updates will be listed below

Genetic alterations of TP53 and OTX2 indicate increased risk of relapse in WNT medulloblastomas: “it’s a numbers game”—implications for WNT medulloblastoma dose-reduction clinical trials

Crossref DOI link: https://doi.org/10.1007/s00401-022-02518-0

Published Online: 2022-11-20

Published Print: 2023-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark